PTC Therapeutics, Inc. (PTCT)
NASDAQ · Healthcare
PTC Therapeutics, Inc. EPS 2011–2025
PTC Therapeutics, Inc. annual/quarterly eps history and growth rate from 2011 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- PTC Therapeutics, Inc. eps for the quarter ending March 31, 2026 was $0.03, a 100.30% decrease year-over-year.
- PTC Therapeutics, Inc. annual eps for 2025 was $7.78, a 264.48% decrease from 2024.
- PTC Therapeutics, Inc. annual eps for 2024 was $4.73, a 43.49% decrease from 2023.
- PTC Therapeutics, Inc. annual eps for 2023 was $8.37, a 7.45% increase from 2022.
- PTC Therapeutics, Inc. annual eps for 2022 was $7.79.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Ptc Therapeutics Inc. EPS — FAQ
Ptc Therapeutics Inc. (PTCT) eps over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Ptc Therapeutics Inc.'s eps?
Ptc Therapeutics Inc. (PTCT) reported eps of $7.78 for fiscal 2025.
Where can I see PTCT's eps history?
The chart and table above show Ptc Therapeutics Inc.'s eps by year and by quarter, including the growth rate.